Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 2 | Unknown | PO / MO |
Patient missed the third dose of Vivotif on Saturday; Case reference number US-BN-2025-000342 is a spontaneous case report initially received from a consumer via Communication (reference number: USBAV25-0516) on 07-Mar-2025 and concerns a female patient of unspecified age. The patient's relevant medical history and concomitant medications were not provided. On an unspecified date, on Tuesday, the patient took first dose of Vivotif vaccine (batch number: unknown) at an unknown dose, orally for unknown indication. On an unspecified date, unknown of time after first dose, reported as last night, the patient took second dose of Vivotif vaccine (batch number: unknown) at an unknown dose, orally. As reported, the patient missed a third dose of Vivotif on Saturday because the patient was out of town and did not bring the vaccine on a cold pack along (explicitly coded as 'missed dose') At the time of the initial report, it was unknown if the patient experienced any adverse events due to Vivotif vaccine. Additional information received from consumer via Communications (reference number: USBAV25-0540) on 10-Mar-2025: Information included additional reporter and reference number, confirmation that the patient missed third dose of Vivotif.; Reporter's Comments: A female patient of unspecified age missed a third dose of Vivotif on Saturday because the patient was out of town and did not bring the vaccine on a cold pack along, which is considered as missed dose. It was unknown if the patient experienced any adverse events due to Vivotif vaccine. Product dose omission issue is considered as listed per company convention. The patient's relevant medical history and concomitant medications were not provided. Product dose omission issue is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A female patient of unspecified age missed a third dose of Vivotif on Saturday because the patient was out of town and did not bring the vaccine on a cold pack along, which is considered as missed dose. It was unknown if the patient experienced any adverse events due to Vivotif vaccine. Product dose omission issue is considered as listed per company convention. The patient's relevant medical history and concomitant medications were not provided. Product dose omission issue is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None.